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ORIGINAL ARTICLE
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Abstract
Background Conversion and anastomotic leakage in colorectal cancer surgery have been suggested to have a negative impact on
long-term oncologic outcomes. The aim of this study in a large Dutch national cohort was to analyze the influence of conversion
and anastomotic leakage on long-term oncologic outcome in rectal cancer surgery.
Methods Patients were selected from a retrospective cross-sectional snapshot study. Patients with a benign lesion, distant
metastasis, or unknown tumor or metastasis status were excluded. Overall (OS) and disease-free survival (DFS) were compared
between laparoscopic, converted, and open surgery as well as between patients with and without anastomotic leakage.
Results Out of a database of 2095 patients, 638 patients were eligible for inclusion in the laparoscopic, 752 in the open, and 107
in the conversion group. A total of 746 patients met the inclusion criteria and underwent low anterior resection with primary
anastomosis, including 106 (14.2%) with anastomotic leakage. OS and DFS were significantly shorter in the conversion com-
pared to the laparoscopic group (p = 0.025 and p = 0.001, respectively) as well as in anastomotic leakage compared to patients
without anastomotic leakage (p = 0.002 and p = 0.024, respectively). In multivariable analysis, anastomotic leakage was an
independent predictor of OS (hazard ratio 2.167, 95% confidence interval 1.322–3.551) and DFS (1.592, 1077–2.353).
Conversion was an independent predictor of DFS (1.525, 1.071–2.172), but not of OS.
Conclusion Technical difficulties during laparoscopic rectal cancer surgery, as reflected by conversion, as well as anastomotic
leakage have a negative prognostic impact, underlining the need to improve both aspects in rectal cancer surgery.
Keywords Rectal cancer . Laparoscopy . Conversion . Anastomosis . Survival
Introduction
Total mesorectal excision (TME), being the cornerstone of
rectal cancer treatment, has gradually evolved in the past de-
cade from open surgery to a laparoscopic approach, as it has
shown advantageous short-term outcomes and a lower post-
operative complication rate, including less pain, improved
recovery time, and less blood loss.1–3 Its oncologic safety
and equivalence to open surgery has been demonstrated in a
number of randomized clinical trials.4–9 However, TME sur-
gery, both open and laparoscopic, is still associated with con-
siderable morbidity. Both intra-operative and postoperative
complications have been associated with shorter overall sur-
vival and unfavorable oncologic outcomes,10,11 although
some studies failed to show a direct relationship.12,13 Due to
the complex nature of the procedure, conversion from laparo-
scopic to open surgery is still reported in up to 30% of cases.14
Subgroup analysis in the CLASSIC trial has suggested an
inferior overall survival in converted patients compared to
patients in whom laparoscopic resection was completed suc-
cessfully, and even worse outcomes compared to primary
open resection as well.6 In addition, several cohort studies
have been published reporting the long-term oncologic out-
come in patients who were converted during laparoscopic co-
lorectal cancer surgery.14 Although some studies have shown
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significant differences in long-term oncologic outcome be-
tween the laparoscopic and converted patients, other studies
have failed to confirm these differences. Additionally, the vast
majority of these studies included both colon and rectal cancer
patients and did not report the outcomes for colon and rectal
cancer patients separately. The few studies that merely report-
ed on rectal cancer patients only included a small patient pop-
ulation. Due to these drawbacks, it is unclear from the current
literature what the real influence of conversion on the long-
term outcome in rectal cancer patients is.
Furthermore, in the direct postoperative phase, anastomotic
leakage (AL) with a reported incidence ranging from 4 to 19%
remains a major source of morbidity and also mortality. A
comprehensive meta-analysis showed the negative impact of
AL on oncologic outcome,10 although other studies did
not.12,13 In addition, most of these studies provide retrospec-
tivemono-center cohort series with variable definitions of AL.
The aim of this study in a large Dutch national cohort of
patients with rectal cancer was to analyze the influence of
conversion in the subgroup of patients who were intentionally
treated by laparoscopy as well as the influence of AL in the
subgroup of patients who underwent low anterior resection




A resident-led, retrospective cross-sectional snapshot study, a
method first described by Bhangu et al.,15 was conducted in
71 hospitals in the Netherlands. This included all consecutive
patients who underwent surgery for primary rectal cancer
from January to December 2011. It was executed as collabo-
rative research under the name of the Dutch Snapshot
Research Group (DSRG), in collaboration with the Dutch
Surgical Colorectal Audit (DSCA).
Ethics
The Medical Ethical Committee of the Academic Medical
Centre in Amsterdam, the Netherlands, reviewed and ap-
proved the study design and judged that no informed consent
from the included patients was necessary considering the ob-
servational study design with no additional burden for the
patient.
Data Extraction
The methodology of this snapshot study has been described
elaborately in the first publication of the DSRG.16 Briefly, all
patients who had resection for rectal cancer in 2011 were
identified from the DSCA. Existing data from the DSCAwere
completed by the snapshot study, including additional data on
diagnostic and treatment characteristics and long-term surgi-
cal and oncologic outcomes. Every participating hospital had
one or two surgical residents who, supervised by a surgeon,
were responsible for collection of additional data that subse-
quently could be entered into a web-based tool which was
specifically developed and controlled on privacy regulations.
Patients
For the current analysis, all patients with invasive rectal cancer
were selected from the database. Patients who underwent re-
section for a benign lesion, i.e., polyp (T0 or Tis), as well as
patients with distant metastasis or patients in whom the tumor
(T) or metastasis (M) status was unknown, were excluded.
For analysis with regard to surgical approach, patients were
subdivided into three groups: patients in whom resection was
successfully completed by laparoscopy (laparoscopic group),
patients who were converted to open surgery after initial lap-
aroscopic approach (conversion group), and patients who
were primarily operated on by an open approach (open
group). Long-term oncologic outcome, i.e., overall (OS) and
disease-free survival (DFS) as well as local and distant recur-
rence, in the conversion group was compared to the successful
laparoscopic as well as to the primary open group.
For analysis of the AL group, only patients who underwent
low anterior resection (LAR) with primary anastomosis with
or without diverting ileo- or colostomy were included.
Patients who had LAR after previous transanal endoscopic
microsurgery (TEM) were excluded. In the included group
of patients, long-term oncologic outcome in patients who de-
veloped AL during the postoperative period (within 30 days
from surgery) was compared to patients who did not have AL.
In addition, OS and DFS were also compared between pa-
tients with and without protective ileo- or colostomy in the
subgroup of patients with AL.
LAR was defined as total or partial mesorectal excision
with the formation of a primary colorectal or colo-anal anas-
tomosis. AL was defined as the presence of contrast extrava-
sation, presacral fluid collection, or presacral sinus on imaging
studies requiring surgical, radiological, or endoscopic
intervention.
Statistical Analysis
Data were analyzed using SPSS 17.0 for Windows (SPSS
Inc., Chicago, IL, USA). Continuous values were expressed
as mean ± standard deviation (SD) or median (range), depend-
ing on whether the data were normally distributed or not,
respectively. Categorical data were reported as frequencies
with percentages. The t test for independent samples was used
for statistical analysis of continuous values between groups.
J Gastrointest Surg
Statistical analysis of categorical values between groups was
performed by using the Pearson chi-square test or Fisher’s
exact test, where appropriate. The Kaplan-Meier method
was used to report OS and DFS, and the log-rank test for
statistical analysis between groups. Differences between
groups were considered statistically significant with p value
less than 0.05.
Uni- and multivariable Cox regression analysis was per-
formed to identify independent predictive variables for OS
and DFS in the group of patients in whom the initial approach
was by laparoscopy (independently whether conversion was
necessary or not, i.e., patients from the laparoscopic and from
the conversion group were included and patients from the
open group were excluded for this analysis) as well as in the
group of patients who had LAR with primary anastomosis.
First, univariable analysis was performed in both separate
groups for OS as well as DFS by the Kaplan-Meier method
and differences between groups were analyzed using the log-
rank test. The variables tested were gender, age, body mass
index, ASA score, tumor stage, nodal status, positive resection
margin, multi-visceral resection, intra-operative and postoper-
ative complications, and postoperative transfusion needed. In
the laparoscopic group, conversion was also added as variable
and AL was added as variable in the group of patients with
LAR and primary anastomosis. Variables with p < 0.10 in
univariable analysis were entered together into a multivariable
analysis performed by Cox regression analyses. Variables
with p < 0.05 in multivariable analysis were considered to be
significant predictors of survival. The hazard ratio and 95%
confidence interval were presented for every predictive vari-
able in multivariable analysis.
Results
The snapshot database contained a total of 2095 patients.
Distant metastases were present in 163 patients (7.8%), and
in 177 patients (8.4%), M-status was unknown (Mx). Tumor
status was unknown (Tx) in 45 patients (2.1%) and 133 pa-
tients (6.3%) had a benign rectal lesion. In the latter two
groups, a total of 25 patients had distant metastasis or un-
known M-status. In 105 patients, T and/or M-status were not
reported in the database. All these patients were excluded for
analysis in the present study.
Conversion
For analysis with regard to surgical approach, 638 patients
were available for inclusion in the laparoscopic group, 752
in the open group, and 107 in the conversion group.
Reasons for conversion were insufficient abdominal access
in 82 patients (76.6%), tumor-related factors in 15 (14.0%),
and intra-operative complication in eight patients (7.5%). The
reason for conversion was not reported in the remaining two
patients. The baseline characteristics of the three separate
groups are shown in Table 1. Body mass index was signifi-
cantly higher in the conversion group compared to both other
groups. In addition, more ASA III/IV patients and more pa-
tients with T4 tumor were included in the conversion group
compared to the laparoscopic group. There was no significant
difference between the groups for the other baseline charac-
teristics. With regard to intra- and postoperative data, there
was a significant difference in the type of rectal resection
between the laparoscopic and conversion group and there
were more multi-visceral resections in the latter group
(Table 2). In addition, there were more intra-operative com-
plications, more postoperative blood transfusions needed, and
longer hospital stay in the conversion compared to the laparo-
scopic group, whereas postoperative morbidity and mortality
was not different between both groups. Comparison of the
open and conversion group showed a significant difference
in the type of ostomy and in addition, significantly more post-
operative blood transfusions were needed in the conversion
group (Table 2).
Anastomotic Leakage
From the snapshot database, a total of 998 patients underwent
LAR with primary anastomosis with or without diverting os-
tomy. After exclusion of patients who met the exclusion
criteria as described, 746 patients, including 106 (14.2%) with
AL, were available for analysis in the present study. There
were no statistically significant differences between both
groups with regard to baseline characteristics (Table 1).
During the postoperative period, more blood transfusions
were needed in the group of patients with AL and hospital
stay was significantly longer in this group (Table 2).
Long-term Oncologic Outcome
Time to long-term follow-up in every group is shown in
Table 1. With regard to OS, the laparoscopic group had a
significantly better OS compared to the conversion group
(p = 0.025), although a significant difference between the pri-
mary open and conversion group was not found (Fig. 1). With
regard to DFS, there was a significant difference between the
conversion and laparoscopic group in favor of the latter one
(p = 0.001, Fig. 1). In addition, DFS was also significantly
worse after conversion compared to primary open surgery
(p = 0.016). OS and DFS were significantly worse in patients
with AL compared to patients without AL (Fig. 2). In the
group of patients with AL, the presence of a diverting ileo-
or colostomy had a negative effect on OS, but there was no
significant difference with regard to DFS (Fig. 3).
There was no significant difference in local recur-






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































vs. conversion group (n = 32 (5.2%), n = 43 (6.1%), and
n = 8 (8.1%), respectively) nor between patients with or
without AL (n = 4 (3.8%) and n = 21 (3.3%), respective-
ly). However, there was a significant difference in dis-
tant metastasis rate between the laparoscopic and con-
version group (n = 110 (18.0%) vs. n = 31 (31.2%), p =
0.004). Differences between both groups for specific
locations of distant metastasis, i.e., liver, pulmonary,
para-aortal lymph node, bone, or peritoneal, were not
found. There was no significant difference in distant
recurrence rate found between patients with or without
AL (n = 24 (22.9%) and n = 116 (18.3%), p = 0.287).
Patients at risk Total 12 months 24 months 36 months 48 months
Laparoscopic group 612 568 512 453 109
Conversion group 99 92 80 70 18
Open group 706 653 586 507 156
Patients at risk Total 12 months 24 months 36 months 48 months
Laparoscopic group 605 532 458 398 92
Conversion group 98 80 65 52 13
Open group 695 592 506 437 192
P-values:
Conversion vs. lapsc 0.025
Conversion vs. open 0.167
P-values:
Conversion vs. lapsc 0.001
Conversion vs. open 0.016
Fig. 1 Kaplan-Meier curves of overall and disease-free survival according to surgical approach
Patients at risk Total 12 months 24 months 36 months 48 months
No anastomotic leakage 620 589 549 485 142
Anastomotic leakage 100 93 86 76 15
Patients at risk Total 12 months 24 months 36 months 48 months
No anastomotic leakage 615 554 486 427 122
Anastomotic leakage 100 85 73 61 13
P-value: 0.002
P-value: 0.024
Fig. 2 Kaplan-Meier curve of overall and disease-free survival in patients with or without anastomotic after LAR and primary anastomosis
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Uni- and Multivariable Analysis
The results of uni- and multivariable analysis for OS and DFS
in the laparoscopic group are shown in Table 3. For OS, 10
variables found in univariable analysis were entered into mul-
tivariable analysis. Finally, five variables were identified as
significant predictors of OS in the laparoscopic group, includ-
ing age > 60 years, ASA score, nodal status, positive resection
margin, and postoperative transfusion needed. For DFS, six
out of nine variables remained as significant predictors in the
laparoscopic group: ASA score, nodal status, positive resec-
tion margin, multi-visceral resection, conversion, and postop-
erative complications.
For patients who underwent LAR with primary anastomo-
sis, results of uni- and multivariable analysis for OS and DFS
are shown in Table 4. For OS, age > 60 years, nodal status,
positive resection margin, AL, and postoperative transfusion
neededwere independent predictors. Four variables, including
nodal status, positive resection margin, AL, and postoperative
transfusion needed, were significant predictors of DFS in this
group.
Discussion
The results of this large national cohort study showed that
patients requiring conversion in laparoscopic rectal cancer
surgery, compared to patients in whom resection was success-
fully completed by laparoscopy, had a significantly worse OS
and DFS. However, conversion was only an independent
predictor of DFS and not of OS after correction for con-
founders. Postoperative AL after rectal resection with primary
anastomosis also had a negative impact on OS and DFS, and
AL was identified as independent predictor of worse OS as
well as DFS.
Although multiple studies have shown a relationship be-
tween AL and disease recurrence as well as OS,17–21 other
studies have not found an adverse effect on oncologic out-
come as was demonstrated in the present patient cohort.12,22
This might be depending on the various definitions of AL
used in the different studies. In the current study, patients with
a proven leak on imaging requiring a radiological or surgical
intervention were included in the leak group. In the case of
successful conservative treatment, patients were included in
the non-leakage group. The results of our cross-sectional
snapshot study are in accordance with several earlier reports
that were comprehensively evaluated in a meta-analysis by
Mirnezami et al.10 Their results show a distinct negative prog-
nostic impact of AL on local recurrence and long-term surviv-
al in rectal cancer patients. However, many studies included in
this meta-analysis are outdated and provide scarce or no in-
formation on neo-adjuvant therapies or operation techniques,
including TME. More recently, Lu et al. included 11 cohort
studies in their meta-analysis and concluded that AL follow-
ing rectal cancer resections using TME had an adverse impact
on cancer specific mortality and the rate of local recurrence.23
Our study provides detailed pre- and intra-operative informa-
tion combined with long-term follow-up, exclusively focusing
on rectal cancer. This enabled us to correct for several poten-
tial confounding factors, such as BMI, ASA classification,
Patients at risk Total 12 months 24 months 36 months 48 months
No protective ostomy 34 34 33 29 4
Protective ostomy 66 59 53 47 11
Patients at risk Total 12 months 24 months 36 months 48 months
No protective ostomy 34 31 29 22 3





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































intra-operative complications, and tumor stage. The underly-
ing pathophysiological mechanism remains largely conceptu-
al. Several experimental models have demonstrated that in-
flammation provides a micro-environment that facilitates ad-
hesion and outgrowth of exfoliate tumor cells or micro-
metastases.24 In addition, prolonged sepsis and inflammatory
responses have been shown to be independent predictors of
poor survival possibly caused by a less effective immune re-
sponse against circulating tumor cells.25
The negative impact of conversion on survival can be ex-
plained by the significant difference in several factors between
the laparoscopic and conversion group. In the conversion
group in the current study, body mass index was significantly
higher and more patients had a higher ASA score. In addition,
more patients in the conversion group had a T4 tumor and
consequently, more multi-visceral resections were performed.
A higher BMI and tumor stage in the conversion group was
also reported by others,26–32 and in addition, Biondi et al.33
found that BMI and a higher tumor stage, in addition to tumor
size, were independent predictors of conversion. All these
factors might have a negative impact on oncologic outcome
and survival. In addition, the blood transfusion rate was also
significantly higher in the conversion group. It has previously
been suggested that postoperative blood transfusion might
have a negative impact on oncologic outcomes due to the
release of inflammatory mediators in response to blood
transfusion.34 Since conversion was not identified as an inde-
pendent predictor of OS in multivariable analysis, it is plausi-
ble that the difference in OS between the successful laparo-
scopic and conversion group is caused by the overrepresenta-
tion of the abovementioned factors in the latter group. So, we
cannot conclude that conversion itself negatively influenced
OS. However, conversion was found to be a significant pre-
dictor of DFS, independent of the other factors which were
also included in multivariable analysis. This suggests that, in
addition to the negative factors that were overrepresented in
the conversion group, conversion itself might also have a neg-
ative individual impact on DFS. The worse DFS in the con-
version group as well as the identification of conversion as
independent predictor of DFS might be explained by a signif-
icantly higher distant metastasis rate in the conversion com-
pared to the successful laparoscopic group. It has been sug-
gested that conversion, due to the more extensive tissue dis-
section, leads to an inflammatory response that compromises
the immune system which has a negative impact on oncologic
outcome with a higher risk of distant metastasis as a
consequence.35
Multivariable analysis in the laparoscopic group in the cur-
rent study identified five independent predictors for OS (age,
ASA score, nodal status, positive resection margin, postoper-
ative transfusion) and six for DFS (ASA score, nodal status,
positive resection margin, multi-visceral resection, conver-
sion, postoperative complications). Allaix et al.26 also
performed a multivariable analysis in a cohort of patients
who underwent laparoscopic colorectal cancer resection.
They found tumor stage and lymph node ratio as independent
predictors of survival. Franko et al.36 identified age and tumor
stage as independent predictors and Li et al.37 found, in a
cohort of colon cancer patients, tumor stage and poor differ-
entiation as independent predictors of OS and tumor stage,
poor differentiation, AL, and no adjuvant chemotherapy as
predictors of DFS. In none of these studies, conversion was
identified as predictor of survival as we did for DFS.
Previous studies also comparing the long-term oncologic
outcome in successful laparoscopy vs. conversion in colorec-
tal cancer surgery were recently summarized in a review.14
There were three studies showing a significant difference in
OS26,31,33 and five in DFS,26,30,33,38,39 all in favor of the suc-
cessful laparoscopic group. However, all of these studies in-
cluded a heterogeneous group of patients with colon as well as
rectal cancer patients. A total of four studies included in this
review only reported on rectal cancer patients and in none of
these a significant difference in survival was found.27,29,40,41
This is probably due to the relatively small number of patients
included in those studies as no more than 300 patients were
included in the largest one. So, although the study design of
the current snapshot study is retrospective, the relatively large
patient population increases statistical power. Hereby, we
were, for the first time, able to identify a negative impact of
conversion on DFS in laparoscopic rectal cancer surgery.
In addition to the retrospective study design, the lack of data
on the number, volume, and level of skills training of the indi-
vidual surgeons involved was another limitation of the current
study as variability in expertise might be related to AL and
conversion rate. However, a certain level of expertise and a
minimal annual volume of 20 rectal resections is required in
the Netherlands to be able to perform rectal cancer surgery
guaranteeing the quality of surgery. In addition, the hospital
volume was the subject of another analysis with the complete
cohort of 2095 patients in this snapshot study and no significant
impact of hospital volume on rectal cancer surgery outcomewas
found in that analysis.42 Finally, the influence of adjuvant che-
motherapy could not be analyzed in the current study, because
adjuvant chemotherapy in rectal cancer is not recommended
according to the national guideline in the Netherlands.43,44
Conclusion
Technicaldifficultiesduringlaparoscopicrectalcancersurgery,as
reflected by conversion, have an independent impact on long-
term outcome, i.e., on DFS, after nationwide implementation of
the technique.Also,anastomotic leakagehasaprognostic impact,
underlining the need to improve both aspects of rectal cancer
surgery.
J Gastrointest Surg
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